Skip to content

Efficacy of darvyadi kwath on ekkustha wsr to plaque psoriasis

A clinical study on the efficacy of darvyadi kwath in ekkustha w.s.r. to plaque psoriasis

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050415
Enrollment
40
Registered
2023-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris Health Condition 2: L400- Psoriasis vulgaris Health Condition 3: L400- Psoriasis vulgaris Health Condition 4: L400- Psoriasis vulgaris

Interventions

None listed

Sponsors

Dr vivek raghuwanshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 20 year to 60year, both sexes Patient having the clinical feature of Ek kushtha-(Plaque Psoriasis), Patient having chronicity of psoriasis less than 5 year Patient willing to give consent for trial with firm residential address and contact.

Exclusion criteria

Exclusion criteria: less than 20 year and more than 60 years. Patient suffering from diabetes mellitus, cancer, cardiac problems, uncontrolled hypertension, acquired immunodeficiency syndrome (AIDS), tuberculosis (TB),renal disorder, Other co-skin disease, Pregnant women and lactating mother, Drug or Alcohol Abuse A Known or suspected history of chronic alcohol or drugabuse, Hypersensitivity to any of the drugs to be used in study

Design outcomes

Primary

MeasureTime frame
Improvement in scaling erythemas and itching Timepoint: 45 days

Secondary

MeasureTime frame
Improvement in scalingTimepoint: 6 month

Countries

India

Contacts

Public ContactDr Vijay Bahadur Singh

Government Ayuvedic collge kadamkuwa Patna, 800003

vijay.md09@gmail.com7004642738

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026